KERRI SULLIVAN: Open Payments
NPI 1003590316 · DARTMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 24 payments from 14 companies in 2025. Trend: 2023 $23 · 2024 $567 · 2025 $605
Food & beverage: $605
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $146 |
| Biogen, Inc. | 1 | $116 |
| Otsuka America Pharmaceutical, Inc. | 4 | $71 |
| Sage Therapeutics, LLC | 2 | $46 |
| Indivior Inc. | 1 | $27 |
| Novo Nordisk Inc | 1 | $27 |
| Lilly USA, LLC | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
Products named: ZURZUVAE, VRAYLAR, REXULTI, SUBLOCADE, Wegovy, ZEPBOUND, COBENFY, Jornay PM.
Industry payments across MA — which companies pay providers there.
